MEP21908A - Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same - Google Patents

Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same

Info

Publication number: MEP21908A
Authority: ME; Montenegro
Prior art keywords: preparation; rimonabant; pharmaceutical compositions; compositions containing; containing same
Prior art date: 2001-11-08

Application number

MEP-219/08A

Other languages

Bosnian (bs)

English (en)

Croatian (hr)

Inventor

Alain Alcade

Gilles Anne-Archard

Corinne Gavory

Olivier Monnier

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-08

Filing date

2002-11-04

Publication date

2010-06-10

2002-11-04 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2010-06-10 Publication of MEP21908A publication Critical patent/MEP21908A/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 title 1
229960003015 rimonabant Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MEP-219/08A 2001-11-08 2002-11-04 Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same MEP21908A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0114579A FR2831883B1 (fr)	2001-11-08	2001-11-08	Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
PCT/FR2002/003765 WO2003040105A1 (fr)	2001-11-08	2002-11-04	Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

Publications (1)

Publication Number	Publication Date
MEP21908A true MEP21908A (en)	2010-06-10

Family

ID=8869285

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-219/08A MEP21908A (en)	2001-11-08	2002-11-04	Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same

Country Status (33)

Country	Link
US (2)	US20050043356A1 (es)
EP (1)	EP1446384A1 (es)
JP (2)	JP4181994B2 (es)
KR (2)	KR20050043774A (es)
CN (1)	CN100412063C (es)
AP (1)	AP1830A (es)
AR (1)	AR037253A1 (es)
AU (1)	AU2002350869B2 (es)
BR (1)	BR0213931A (es)
CA (1)	CA2464145A1 (es)
CO (1)	CO5580827A2 (es)
CR (1)	CR7333A (es)
EA (1)	EA006771B1 (es)
EC (1)	ECSP045088A (es)
FR (1)	FR2831883B1 (es)
GE (1)	GEP20063894B (es)
HR (1)	HRP20040403A2 (es)
HU (1)	HUP0402043A3 (es)
IL (2)	IL161533A0 (es)
IS (1)	IS7226A (es)
MA (1)	MA27080A1 (es)
ME (1)	MEP21908A (es)
MX (1)	MXPA04004394A (es)
NO (1)	NO326648B1 (es)
NZ (1)	NZ532369A (es)
OA (1)	OA12721A (es)
PL (1)	PL369372A1 (es)
RS (1)	RS36904A (es)
TN (1)	TNSN04079A1 (es)
TW (1)	TW200302824A (es)
UA (1)	UA76776C2 (es)
WO (1)	WO2003040105A1 (es)
ZA (1)	ZA200402999B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2831883B1 (fr) *	2001-11-08	2004-07-23	Sanofi Synthelabo	Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
NZ537003A (en)	2002-07-18	2008-03-28	Cytos Biotechnology Ag	Hapten-carrier conjugates comprising virus like particles and uses thereof
FR2861992B1 (fr) *	2003-11-10	2007-07-20	Sanofi Synthelabo	Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
EP1910290A2 (en)	2005-06-30	2008-04-16	Prosidion Limited	Gpcr agonists
EP1816125A1 (en) *	2006-02-02	2007-08-08	Ranbaxy Laboratories, Ltd.	Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
FR2897060B1 (fr) *	2006-02-08	2008-07-25	Sanofi Aventis Sa	Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
WO2008038143A2 (en) *	2006-06-22	2008-04-03	Medichem, S.A.	Novel solid forms of rimonabant and synthetic processes for their preparation
AR062593A1 (es) *	2006-08-29	2008-11-19	Medichem Sa	1-{[5-(4-clorofenil)-1-(2,4-diclorofenil)-4-metil-1h-pirazol-3-il]carbonil}-piperidina y proceso para preparar dicho compuesto; proceso para analizar la pureza de rimonabant,proceso para preparar rimonabant,rimonabant que se obtiene mediante dicho proceso y formulaciones.
WO2008026219A2 (en) *	2006-09-01	2008-03-06	Hetero Drugs Limited	Novel polymorphs of rimonabant
EP2061783A2 (en) *	2006-09-11	2009-05-27	Hetero Drugs Limited	Improved process for rimonabant
WO2008035023A1 (en) *	2006-09-19	2008-03-27	Cipla Limited	Polymorphs of rimonabant
WO2008056377A2 (en) *	2006-11-06	2008-05-15	Cadila Healthcare Limited	Polymorphic forms of rimonabant
WO2008064615A2 (en) *	2006-12-01	2008-06-05	Zentiva, A.S.	Crystalline and amorphous forms of rimonabant and processes for obtaining them
EP2121659B1 (en) *	2006-12-18	2013-05-15	7TM Pharma A/S	Modulators of cb1 receptors
PE20081849A1 (es)	2007-01-04	2009-01-26	Prosidion Ltd	Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
EA016507B1 (ru)	2007-01-04	2012-05-30	Прозидион Лимитед	Пиперидиновые агонисты gpcr
CL2008000018A1 (es)	2007-01-04	2008-08-01	Prosidion Ltd	Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
GB0700122D0 (en)	2007-01-04	2007-02-14	Prosidion Ltd	GPCR agonists
US20100048632A1 (en)	2007-01-04	2010-02-25	Matthew Colin Thor Fyfe	Piperidine GPCR Agonists
EP1944297A1 (en) *	2007-01-09	2008-07-16	Miklós Vértessy	Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof
WO2008088900A2 (en) *	2007-01-18	2008-07-24	Teva Pharmaceutical Industries Ltd.	Polymorphic forms of rimonabant base and processes for preparation thereof
EP1953144A1 (en)	2007-01-30	2008-08-06	Sandoz AG	Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide
FR2919863A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de n-methylpyrrolidone de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
FR2919864A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de 1,4-dioxane de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
FR2919862A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de 3-methylbutan-1-ol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
FR2919865A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de dmso de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
FR2919867A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de 2-methoxyethanol de rimonabant et son procede de preparation
GB0720389D0 (en)	2007-10-18	2008-11-12	Prosidion Ltd	G-Protein Coupled Receptor Agonists
GB0720390D0 (en)	2007-10-18	2007-11-28	Prosidion Ltd	G-Protein coupled receptor agonists
WO2009153804A1 (en) *	2008-06-16	2009-12-23	Cadila Healthcare Limited	Process for preparing form i of rimonabant
WO2010079241A1 (es)	2009-01-12	2010-07-15	Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion	Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
FR3008620A1 (fr) *	2013-07-22	2015-01-23	Sanofi Sa	Formulation de comprime d'un inhibiteur de phosphatidylinositol 3-kinase
JP7704681B2 (ja) *	2019-10-16	2025-07-08	大塚製薬株式会社	センタナファジンの製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2692575B1 (fr) *	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr) *	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
US7109245B2 (en) *	2001-08-15	2006-09-19	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Vasoconstrictor cannabinoid analogs
FR2831883B1 (fr) *	2001-11-08	2004-07-23	Sanofi Synthelabo	Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

2001
- 2001-11-08 FR FR0114579A patent/FR2831883B1/fr not_active Expired - Fee Related
2002
- 2002-04-11 UA UA20040402974A patent/UA76776C2/uk unknown
- 2002-11-04 US US10/494,211 patent/US20050043356A1/en not_active Abandoned
- 2002-11-04 EP EP02785580A patent/EP1446384A1/fr not_active Withdrawn
- 2002-11-04 GE GE5606A patent/GEP20063894B/en unknown
- 2002-11-04 BR BR0213931-6A patent/BR0213931A/pt not_active IP Right Cessation
- 2002-11-04 AU AU2002350869A patent/AU2002350869B2/en not_active Ceased
- 2002-11-04 CN CNB028219686A patent/CN100412063C/zh not_active Expired - Fee Related
- 2002-11-04 IL IL16153302A patent/IL161533A0/xx unknown
- 2002-11-04 KR KR1020047006969A patent/KR20050043774A/ko not_active Abandoned
- 2002-11-04 MX MXPA04004394A patent/MXPA04004394A/es unknown
- 2002-11-04 HR HR20040403A patent/HRP20040403A2/hr not_active Application Discontinuation
- 2002-11-04 NZ NZ532369A patent/NZ532369A/en not_active IP Right Cessation
- 2002-11-04 JP JP2003542151A patent/JP4181994B2/ja not_active Expired - Fee Related
- 2002-11-04 PL PL02369372A patent/PL369372A1/xx not_active Application Discontinuation
- 2002-11-04 RS YU36904A patent/RS36904A/sr unknown
- 2002-11-04 HU HU0402043A patent/HUP0402043A3/hu unknown
- 2002-11-04 AP APAP/P/2004/003024A patent/AP1830A/en active
- 2002-11-04 KR KR1020097016373A patent/KR20090089485A/ko not_active Ceased
- 2002-11-04 WO PCT/FR2002/003765 patent/WO2003040105A1/fr not_active Ceased
- 2002-11-04 OA OA1200400131A patent/OA12721A/fr unknown
- 2002-11-04 EA EA200400491A patent/EA006771B1/ru not_active IP Right Cessation
- 2002-11-04 ME MEP-219/08A patent/MEP21908A/xx unknown
- 2002-11-04 CA CA002464145A patent/CA2464145A1/en not_active Abandoned
- 2002-11-06 AR ARP020104228A patent/AR037253A1/es unknown
- 2002-11-07 TW TW091132763A patent/TW200302824A/zh unknown
2004
- 2004-04-19 IS IS7226A patent/IS7226A/is unknown
- 2004-04-20 IL IL161533A patent/IL161533A/en not_active IP Right Cessation
- 2004-04-20 ZA ZA200402999A patent/ZA200402999B/en unknown
- 2004-04-27 EC EC2004005088A patent/ECSP045088A/es unknown
- 2004-04-28 MA MA27659A patent/MA27080A1/fr unknown
- 2004-05-04 CR CR7333A patent/CR7333A/es unknown
- 2004-05-04 CO CO04040840A patent/CO5580827A2/es not_active Application Discontinuation
- 2004-05-07 NO NO20041879A patent/NO326648B1/no not_active IP Right Cessation
- 2004-05-07 TN TNP2004000079A patent/TNSN04079A1/fr unknown
2008
- 2008-07-11 JP JP2008181474A patent/JP4931874B2/ja not_active Expired - Fee Related
- 2008-10-28 US US12/259,701 patent/US20100190827A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HUP0402043A2 (hu)	2005-01-28
EA200400491A1 (ru)	2004-12-30
CR7333A (es)	2008-09-23
JP4931874B2 (ja)	2012-05-16
HUP0402043A3 (en)	2009-07-28
JP2005508383A (ja)	2005-03-31
IL161533A0 (en)	2004-09-27
US20100190827A1 (en)	2010-07-29
PL369372A1 (en)	2005-04-18
NO326648B1 (no)	2009-01-26
FR2831883B1 (fr)	2004-07-23
RS36904A (sr)	2006-10-27
AR037253A1 (es)	2004-11-03
JP4181994B2 (ja)	2008-11-19
EA006771B1 (ru)	2006-04-28
WO2003040105A1 (fr)	2003-05-15
GEP20063894B (en)	2006-08-10
AP1830A (en)	2008-02-22
FR2831883A1 (fr)	2003-05-09
BR0213931A (pt)	2004-09-08
TNSN04079A1 (fr)	2006-06-01
KR20090089485A (ko)	2009-08-21
NZ532369A (en)	2005-10-28
IL161533A (en)	2010-05-31
CN100412063C (zh)	2008-08-20
ZA200402999B (en)	2005-04-20
EP1446384A1 (fr)	2004-08-18
JP2009035547A (ja)	2009-02-19
UA76776C2 (uk)	2006-09-15
KR20050043774A (ko)	2005-05-11
ECSP045088A (es)	2004-06-28
MXPA04004394A (es)	2004-08-11
AP2004003024A0 (en)	2004-06-30
IS7226A (is)	2004-04-19
CO5580827A2 (es)	2005-11-30
OA12721A (fr)	2006-06-27
HRP20040403A2 (en)	2004-08-31
CA2464145A1 (en)	2003-05-15
TW200302824A (en)	2003-08-16
AU2002350869B2 (en)	2007-07-26
US20050043356A1 (en)	2005-02-24
CN1582278A (zh)	2005-02-16
NO20041879L (no)	2004-06-08
MA27080A1 (fr)	2004-12-20
NO20041879D0 (no)	2004-05-07

Publication	Publication Date	Title
MEP21908A (en)	2010-06-10	Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
MXPA05009969A (es)	2006-02-17	Metodo para aislar la forma cristalina i de la 5-azacitidina.
SE0101675D0 (sv)	2001-05-11	Novel composition
NO20044221L (no)	2004-12-06	Nye forbindelser
EP1416933B8 (en)	2008-08-27	Substituted piperidines as modulators of the melanocortin receptor
BRPI0519726B8 (pt)	2021-05-25	composto de hemidrato de (r)-8-cloro-1-metil-2,3,4,5-tetraidro-1h-3-benzazepina, composição compreendendo o referido composto e seus usos
AU7743001A (en)	2002-02-05	Cyclopentanoindoles, compositions containing such compounds and methods of treatment
SE0400284D0 (sv)	2004-02-10	Novel compounds
NO20081001L (no)	2008-03-25	Derivater av karboksamid som antagonister for muskarinisk reseptor
IL160171A0 (en)	2004-07-25	Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
TNSN04024A1 (en)	2006-06-01	Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
PT2049480E (pt)	2013-12-16	Derivados de 2-arilindole como inibidores da mpges-i
UA83648C2 (ru)	2008-08-11	Антагонисты аденозиндифосфатного рецептора тромбоцитов
NO20062021L (no)	2006-07-07	Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
BR0318521A (pt)	2006-09-12	arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
NO20064351L (no)	2006-11-20	Caspaseinhibitorer og anvendelser derav
EA200701687A1 (ru)	2008-02-28	Гидрохлорид аморфного лерканидипина
TR200503401T1 (tr)	2008-03-21	Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
HUP0400391A3 (en)	2008-03-28	New compounds, which are potent inhibitors of na+/ca2+ exchange and pharmaceutical compositions containing them
EP1831239B8 (en)	2010-09-15	A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
NO20041573L (no)	2004-07-07	Aralkyl-tetrahydro-pyridiner, deres fremstilling og farmasoytiske preparater inneholdende de samme
MX2007007899A (es)	2009-02-16	Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
NO20055749L (no)	2005-12-14	Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer
GEP20094744B (en)	2009-07-27	Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
MXPA05006587A (es)	2005-12-14	Compuestos de tiazol como derivados de antagonistas del receptor de la integrina.